Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2021-02-05 Capital/Financing Update
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
6-K
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by PureTech Health plc, which is a report of a foreign private issuer under the Securities Exchange Act of 1934. The content primarily announces a press release about the pricing of an initial public offering (IPO) by a founded entity, Vor Biopharma. The document is short (1698 characters) and mainly serves as an announcement of the IPO pricing press release, not a detailed financial report or earnings release. It does not contain financial statements or substantive financial data. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs.
2021-02-05 English
PureTech Founded Entity Vor Lists on Nasdaq
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement referencing 'RNS, the news service of the London Stock Exchange'. The content announces that PureTech Health's Founded Entity, Vor Biopharma, has priced its Initial Public Offering (IPO). This type of announcement, which is a material corporate event disseminated via the regulatory news service (RNS), fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). While it relates to capital raising (CAP), the primary function of this specific document format is the regulatory dissemination of the news via RNS.
2021-02-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured fields detailing changes in voting rights percentages (crossing thresholds from 28.61% to 24.56%) held by an entity (Invesco Ltd.) in the issuer (PureTech Health PLC). This format is characteristic of regulatory filings concerning significant ownership changes. The presence of 'RNS Number' and the reference to the 'FCA' (Financial Conduct Authority) confirms it is a regulatory disclosure. The specific nature of reporting major shareholdings aligns directly with the definition for Major Shareholding Notification (MRQ).
2021-02-05 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content reports the 'Total Voting Rights and Share Capital' as of a specific month-end date (31 January 2021) and references DTR 5.6.1 (Disclosure Guidance and Transparency Rules). This type of mandatory, periodic disclosure regarding share structure, issued by a company listed on the LSE and distributed via RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights Disclosure'. Given the source (RNS) and the nature of the mandatory regulatory update, RNS is the most appropriate classification.
2021-02-01 English
6-K
Board/Management Information Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It announces the appointment of a new board member, Bharatt Chowrira, to the Board of Directors. The content is a press release about a management change, not a full report or financial statement. The document length is short (1764 characters), and it primarily serves as an announcement of a board/management change. Therefore, the appropriate classification is Board/Management Information (MANG).
2021-01-29 English
PureTech Appoints Bharatt Chowrira to BOD
Board/Management Information Classification · 98% confidence The document is identified by the RNS Number (2951N) and the date (29 January 2021). The core content announces the appointment of an executive, Bharatt Chowrira, to the Board of Directors and lists the current composition of the Board and the R&D Committee. This type of announcement, detailing changes in senior management or the board, directly corresponds to the definition of 'Board/Management Information'. The document is a formal announcement distributed via RNS, but its specific subject matter points to MANG rather than the general RNS fallback.
2021-01-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.